When effort isn't matching results, the problem is almost always metabolic, not motivational. Insulin resistance alone affects approximately 27% of the global adult population. It makes fat loss biochemically harder regardless of calorie deficit, and it is invisible on a standard NHS blood test.
Sources: Global IR prevalence meta-analysis 2025 (87 studies, 235,148 participants, PMID 40917357). CPRD England 2015 (~5M adults with NDH, prevalence 11.4%). British Thyroid Association (SCH prevalence 8-10%). NHS does not routinely test fasting insulin or HOMA-IR.
When you tell your GP you're struggling with weight, they typically test TSH (thyroid) and HbA1c (diabetes). If both are "normal," the investigation stops and the advice defaults to "eat less, move more." But the metabolic systems that actually govern fat storage and release are not on that panel.
Weight loss is a metabolic process. When the metabolic systems that govern fat storage and release are dysfunctional, willpower and calorie counting are fighting the wrong battle. These four systems interact, and testing any one without the others leads to incomplete answers.
When cells become resistant to insulin, your body produces more to compensate. High circulating insulin prevents fat cells from releasing stored fat, regardless of calorie deficit. You can be in a 500-calorie deficit and your body will catabolise muscle before it touches fat stores. Insulin resistance is the single most common metabolic blocker for weight loss, and the NHS does not test for it.
Your thyroid sets your basal metabolic rate. Even mild underactivity reduces the calories you burn at rest by 10 to 20%. Subclinical hypothyroidism affects 8 to 10% of the UK population and is more common in people who are overweight. The NHS tests TSH only. Free T3, the active hormone that actually drives metabolism, is not routinely tested.
Elevated cortisol from chronic stress promotes visceral fat storage, particularly around the abdomen. It simultaneously increases appetite, disrupts sleep (which further impairs metabolism), and suppresses testosterone. Cortisol and insulin resistance create a feedback loop: elevated cortisol worsens insulin resistance, and insulin resistance elevates cortisol. The NHS does not test cortisol for weight concerns.
Testosterone influences lean mass, metabolic rate, and fat distribution in both men and women. Low testosterone makes it harder to build and maintain muscle, which lowers your basal metabolic rate. SHBG determines how much testosterone is free and active. Oestradiol balance affects where fat is stored. The NHS rarely tests any of these for weight-related complaints.
This is why "eat less, move more" fails for so many people. It assumes the metabolic machinery is working correctly. When insulin resistance, thyroid dysfunction, cortisol dysregulation, or hormonal imbalance is present, the machinery is broken. A comprehensive panel identifies which systems are blocked so the fix is metabolic, not motivational.
A 2025 global meta-analysis of 87 studies covering 235,148 participants estimated the pooled prevalence of insulin resistance at 26.53% (95% CI: 24.10 to 29.03). A more recent NHANES analysis found that 40% of US adults aged 18 to 44 are insulin resistant based on HOMA-IR measurements. While UK-specific HOMA-IR population data is limited, the prevalence is unlikely to be substantially different given comparable obesity rates.
The mechanism is straightforward. Insulin tells your cells to take up glucose. When cells become resistant, your pancreas produces more insulin to compensate. High insulin levels block lipolysis, the process by which fat cells release stored fat for energy. You can eat perfectly and train consistently, and your fat stores will not release because insulin is keeping them locked. This is not a willpower failure. It is a biochemical lock.
The NHS tests HbA1c, which measures average blood sugar over three months. NICE NG28 defines pre-diabetes as HbA1c 42 to 47 mmol/mol. But HbA1c is a lagging indicator. Fasting insulin and HOMA-IR rise 5 to 15 years before HbA1c moves. By the time your GP's test catches it, you have been metabolically impaired for years, potentially gaining weight the entire time with no explanation.
An important caveat: HOMA-IR does not have a validated UK diagnostic cut-off. It is a research and clinical adjunct tool, not a standalone diagnostic. Different studies use thresholds ranging from 1.85 to 3.5. TrueVitals reports HOMA-IR as an early metabolic warning marker, not a diagnosis. If elevated, the recommendation is to discuss with your GP and consider dietary and lifestyle interventions that target insulin sensitivity.
The relationship between thyroid function and weight is bidirectional and more complex than most people realise. Hypothyroidism causes weight gain. But obesity itself alters thyroid function, elevating TSH and increasing T4-to-T3 conversion through increased deiodinase activity in adipose tissue. This means obese individuals can have elevated TSH without true thyroid disease, but they can also have genuine subclinical hypothyroidism masked by these compensatory mechanisms.
The critical marker the NHS misses is Free T3. T3 is the active thyroid hormone that directly sets your metabolic rate. Your body produces T4 (inactive) and converts it to T3 in peripheral tissues. Some people convert poorly due to genetics, nutrient deficiencies (selenium, zinc, iron), chronic inflammation, or stress. Their TSH and T4 look normal, but T3 is low. They feel cold, tired, foggy, and they cannot lose weight no matter what they do. This is called poor T4-to-T3 conversion, and it will never show on an NHS panel because Free T3 is not a first-line NHS test.
Thyroid antibodies add another layer. Anti-TPO antibodies, present in Hashimoto's thyroiditis, can be elevated for years before TSH moves out of range. A patient with early Hashimoto's will have fluctuating energy, weight gain, and fatigue, but "normal" TSH. By the time the NHS catches it, the autoimmune process has been running for years. A comprehensive panel catches it at the earliest stage, when intervention is most effective.
Subclinical hypothyroidism is more than twice as common in obese individuals compared to lean individuals. One study found prevalence rates of 10.4% versus 6.4% in overweight/obese versus lean populations. This means the people most likely to struggle with weight are also the most likely to have undetected thyroid dysfunction.
Cortisol is your primary stress hormone. In acute stress, it's useful: it mobilises energy and sharpens focus. In chronic stress, it's destructive. Chronically elevated cortisol promotes visceral fat deposition (the metabolically dangerous abdominal fat), increases appetite for high-calorie foods, disrupts sleep architecture, and directly suppresses testosterone production. The combination of high cortisol and low testosterone is one of the most common hormonal patterns in overweight adults, and the NHS tests neither for weight concerns.
Testosterone matters for weight loss in both men and women. In men, testosterone supports lean muscle mass, which directly determines basal metabolic rate. Low testosterone means less muscle, which means fewer calories burned at rest, which means weight gain even at the same calorie intake. In women, testosterone influences energy, mood, and body composition. SHBG (sex hormone binding globulin) determines how much testosterone is free and active. High SHBG, common in women on hormonal contraception, can leave functionally low free testosterone with "normal" total testosterone.
Oestradiol balance also matters. In men, elevated oestradiol (often from aromatisation of testosterone in adipose tissue) promotes further fat storage, creating a self-reinforcing cycle. In women, oestrogen dominance relative to progesterone is associated with weight gain, water retention, and difficulty losing fat, particularly during perimenopause.
Inflammation is the connective tissue between all of these systems. Chronic low-grade inflammation (measured by hs-CRP) directly impairs insulin signalling, worsens thyroid function, and disrupts hormonal balance. Adipose tissue itself produces inflammatory cytokines, meaning the more overweight you are, the more inflammation you produce, and the harder it becomes to lose weight. A comprehensive panel measures inflammation alongside metabolic and hormonal markers because they cannot be meaningfully interpreted in isolation.
If you're considering or already taking a weight loss injection, a comprehensive baseline blood test is not optional — it's essential. GLP-1 medications affect liver function, kidney function, thyroid markers, and metabolic health. Many online prescribers require no blood test at all, which is a genuine safety gap.
A baseline before starting lets you track how the medication is affecting your body. A follow-up at 3 months catches side effects early and confirms the medication is working as expected. The TrueVitals Ultimate panel covers every marker recommended for GLP-1 monitoring: HbA1c, fasting insulin, liver function, kidney function, lipids, thyroid, and nutritional markers. Read our full Mounjaro blood test guide.
Every TrueVitals panel includes AI-powered cross-system analysis that processes over 6,400 possible biomarker interactions. It doesn't just tell you your insulin is high. It tells you what your insulin means alongside your thyroid, cortisol, and hormonal balance, and gives specific recommendations based on the metabolic pattern.
Fasting insulin, HOMA-IR, HbA1c, fasting glucose, C-peptide, full thyroid (TSH, Free T4, Free T3, antibodies), cortisol, testosterone, SHBG, oestradiol, and inflammatory markers. Every system that controls fat metabolism, tested in a single blood draw.
High insulin plus low Free T3 plus elevated cortisol is a specific metabolic pattern that needs a specific intervention. The AI identifies these cross-system patterns and explains them in plain English, so you know exactly what to address first.
Based on your actual metabolic data, not generic advice. If insulin resistance is the primary blocker, the recommendations target insulin sensitivity. If thyroid conversion is the issue, the recommendations are different. No more guessing.
Retest in 3 to 6 months to see whether your interventions are working. The progress report tracks every marker with directional arrows and percentage change. Weight loss is a process, and data turns that process into something you can measure and adjust.
114 biomarkers. AI-powered metabolic analysis. Every system that controls fat loss, tested in one blood draw. Results in 48 hours.
.png)